AZ’ COPD therapy wins US approval
Breztri Aerosphere is also under regulatory review in the EU
Read More
Tag: Ethos
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial
The triple therapy is currently under review for COPD in both the EU and US
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
